1.be able to identify the patients who have developed cardiogenic shock who will not respond to traditional pharmacotherapy; apply the recently published data on novel mechanical cardiopulmonary support to the clinical benefit of patients; recognize that every patient may need a different pathway for support during cardiogenic shock.





Session date: 
04/22/2016 - 12:00pm to 1:00pm CDT
Little Company of Mary Hospital
Evergreen Park, IL 60805
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Atman Shah